Benefits of Jing-Si-Herbal-Tea in Bronchiectasis
Key facts
- Who runs it
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 25 people enrolled
- Started
- 1 Jan 2024
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Jing-Si Herbal Tea
- Placebo
- Record updated
- 30 March 2025
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18 years or older
- Clinically diagnosed with bronchiectasis
- Willing to participate in the study
- Signed an informed consent form
Who cannot take part
- Individuals with severe kidney diseases
- Pregnant or breastfeeding women
- Individuals with severe liver
- Individuals who refuse to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Patients are divided into two groups: the usual care group (UC group) and the Jing-Si Herbal Tea group (JSHT group).
Read full original descriptionShow less
* **UC Group**: Receives standard treatment and one placebo packet daily for three months. * **JSHT Group**: Receives standard treatment plus one packet of Jing-Si Herbal Tea daily for three months.
Each group includes 30 participants. The study runs from January 1, 2014, to December 31, 2014. Exclusions include severe liver or renal dysfunction and allergy to Jing-Si Herbal Tea. Participants must follow the study protocol.
**Assessments**:
* **HRQL**: Measured using the COPD Assessment Test (CAT) and the Modified Medical Research Council (mMRC) scale. * **Blood Tests**: Include WBCs, hemoglobin, hematocrit, platelets, BUN, creatinine, uric acid, liver enzymes, electrolytes, CRP, and pPro-BNP. Blood samples will also be analyzed for DAMPs and inflammatory cytokines. * **Pulmonary Function Tests (PFT)**: Conducted with a spirometer per American Thoracic Society guidelines.
The 2 groups in the trial
- usual care group (UC group)Placebo, for comparison
The UC group will receive standard medical treatment, with one placebo packet daily for three months.
Treatment: Placebo
- Jing-Si Herbal Tea group (JSHT group)Treatment being tested
The JSHT group will receive the standard medical treatment along with Jing-Si Herbal Tea, one packet daily for three months.
Treatment: Jing-Si Herbal Tea
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 March 2025